Press Releases
XTANDI approved by U.S. FDA for the treatment of...
Pfizer Inc and Astellas Pharma Inc announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) for the treatment...
Press Releases
Novartis announces partnership with Amazon to digitally transform operations
Novartis will work with Amazon Web Services (AWS) to increase efficiencies across its manufacturing, supply chain and delivery operations. The company will use AWS’ portfolio...
Press Releases
Catalent Partners with Bridge Therapeutics on Formulation, Development and...
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products announced that it...
Clinical Trials
Symbiosis invests $1.5 million in UK facility expansion
Stirling, UK – Fast-growing specialist sterile manufacturing and Contract Manufacturing Organisation (CMO) Symbiosis Pharmaceutical Services (Symbiosis), has expanded its sterile biologics manufacturing facility in Scotland,...
Drug Research
Aptar Pharma to Highlight Drug Delivery Solutions Portfolio and...
Aptar Pharma, a global leader in drug delivery systems and active packaging solutions, announces that it will be a leading exhibitor at Pharmapack 2020, which...
Packaging & Labelling
FedEx Express Strengthens Clinical Trial Logistics Services for Global...
Following the completed renovation of the TNT Life Science Center in Tokyo, Japan in May 2019, FedEx Express is bolstering its healthcare solutions to support...
Drug Research
Novartis and Forendo enter into tissue hormone focused licensing...
Finland-based Forendo Pharma has announced it has signed a licensing and collaboration agreement with Novartis.
The research collaboration will focus on discovering and developing HSD17B (17-beta-hydroxysteroid...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.